Johnson & Johnson
JNJ
Below: live stock price for Johnson & Johnson (JNJ), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
Johnson & Johnson (JNJ) trades at 263.73 USD on cryptosrank.
- Prev close
- $261.44
- Volume (24h)
- $1.47B
- Market cap
- $635.56B
- Currency
- USD
Score
Insufficient data
- Value—
- Quality—
- Momentum—
- Growth—
- Risk—
- Dividend—
- Liquidity—
Composite of public market data. Informational only — not investment advice.
Trend projection
Where the recent trend points if it continues.
- +5 bars
- 264.1539 +0.16%
- +20 bars
- 264.7399 +0.38%
- +60 bars
- 264.9669 +0.47%
- +120 bars
- 264.9752 +0.47%
Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0248 USD.
Interpretation
Price sits in the middle of the recent range, trend is roughly flat.
Descriptive observation — not investment advice.
Price report
How this asset has actually moved over the last 251 days.
Where the price sits between the window low and high.
- Volatility (annualised)
- 19.3%
- Max drawdown
- -11.0%
- Below period high
- -6.2%
- Best day
- +3.99%
- Worst day
- -3.66%
- Up days
- 53%
- Current streak
- 2 up
- Typical day swing
- 1.8%
- Volume vs average
- -4%
Spread of returns. Higher means larger swings in both directions.
Worst peak-to-trough fall inside the window.
Current price against the highest point in the window.
Share of days that closed above the one before.
Average high-to-low spread within a single day.
Last 10 days against the whole window.
Descriptive statistics over past prices — not a forecast and not investment advice.
Reference levels
Fibonacci retracements and extensions across the recent range.
Reference only — not investment advice.
These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.
Levels derived from: 281.07 high → 245.49 low · 60 bars
- ResistanceFib +161.8% extensionnot reached338.6385 USD+28.40% from current
- ResistanceFib +100% extensionnot reached316.65 USD+20.07% from current
- ResistanceFib +61.8% extensionnot reached303.0584 USD+14.91% from current
- ResistanceFib +27.2% extensionnot reached290.7478 USD+10.24% from current
- ResistanceFib 23.6% retracementtested 9×272.6731 USD+3.39% from current
- ResistanceFib 38.2% retracementtested 22×267.4784 USD+1.42% from current
- Current263.73 USD
- SupportFib 50% midpointNearesttested 7×263.28 USD-0.17% from current
- SupportFib 61.8% retracementtested 13×259.0816 USD-1.76% from current
- SupportFib 78.6% retracementtested 7×253.1041 USD-4.03% from current
- SupportFib −27.2% extensionnot reached235.8122 USD-10.59% from current
- SupportFib −61.8% extensionnot reached223.5016 USD-15.25% from current
- SupportFib −100% extensionnot reached209.91 USD-20.41% from current
How to read this
We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.
“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.
This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.
Recent news
- TREMFYA® (guselkumab) demonstrated sustained clinical and endoscopic remission through 3 years in moderately to severely active Crohn's diseasePR Newswire39m ago
- New TREMFYA® (guselkumab) study shows consistent perianal fistula remission across key Crohn's disease patient subgroupsPR Newswire39m ago
- Has Medtronic Stock Become A Different Bet?Trefis3h ago
- Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool4h ago
- Stryker enters soft tissue robotics with $400M investment in CMR SurgicalMedTech Dive4h ago
- Will Skyrizi & Rinvoq Drive AbbVie's Top-Line Growth in Q3?Zacks6h ago
- Big Week of Data: Inflation & Q3 EarningsZacks7h ago
- Update: US Equity Futures Mostly Flat Pre-Bell Ahead of Week of Earnings, Economic DataMT Newswires7h ago
Related
Other assets in this category.
- 8306.TMitsubishi UFJ Financial Group, Inc.3,462 USD-1.20%
- 7203.TToyota Motor Corporation2,910.5 USD+0.29%
- 9984.TSoftBank Group Corp.5,803 USD-3.92%
- 6758.TSony Group Corporation3,814 USD+2.91%
- 6861.TKeyence Corporation80,540 USD+0.68%
- NVDANVIDIA Corporation226.32 USD-1.29%
- AAPLApple Inc.340.97 USD+1.29%
- GOOGLAlphabet Inc.352.72 USD+0.30%
Learn the terms
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.